Revanesse Lips™+

Revanesse Lips+ is a biocompatible, biodegradable, non-pyrogenic, sterile, injectable viscoelastic hydrogel, clear and colourless, from Prollenium Medical Technologies in Aurora, Canada, developed for lip augmentation. It is indicated for submucosal implantation in patients 22 years of age or older and is FDA approved under PMA P160042/S010. The gel carries 25 mg/mL of bioresorbable, BDDE cross-linked hyaluronic acid, produced by the Streptococcus species of bacteria, with 0.3% lidocaine and is intended for professional use. A box holds two 1.2 mL glass syringes and two 0.5 inch 30-gauge sterile needles.

*Note: This product is FDA-approved in the United States. Regulatory status and availability may vary by country. Please contact ALLPARA to confirm availability for your market.

• BDDE cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine
• Indicated specifically for lip augmentation by submucosal implantation
• FDA approved under PMA P160042/S010
• Supplied with two 0.5 inch 30-gauge sterile needles
• Supplied as two 1.2 mL glass syringes per box
• Hyaluronic acid produced by the Streptococcus species of bacteria
• Removable label portion for the patient record

適応と専門的な使用

主な適応

• Lip augmentation by submucosal implantation

専門的な使用

For professional use. Revanesse Lips+ is administered by qualified physicians trained in the proper injection technique, and is not for retail sale or self-administration. It is placed by submucosal implantation in the lip using the 0.5 inch 30-gauge needles supplied. Its approval was supported by two clinical studies: a multicentre, double-blind, randomised, controlled treatment study enrolling 158 subjects over 10 months, and a multicentre, open-label retreatment study of 84 of those subjects over a further 8 months, with lip fullness assessed on the 5-point Lip Fullness Grading Scale.

施術部位

• Lips

対象となる患者

Indicated for patients 22 years of age or older seeking lip augmentation. It must not be used in patients who develop hypertrophic scarring or keloid formation, in patients with evidence of scars at the intended treatment sites, in patients with acne or other inflammatory skin disease, in patients with multiple severe allergies or a history of allergy, or in patients with unattainable expectations. It must never be used in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion treatments, or with over-the-counter or prescription wrinkle treatments within 4 weeks of treatment.

作用の仕組み： Revanesse Lips™+ ​

Allparaで注文する理由

Allparaは、正規品で検証済みの REVANESSE 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問